23andMe independent directors resign from board: Read the CEO …
WEB2 days ago · Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023. All seven independent ...
23andMe Agrees to $30M Settlement That Could Pay $10,000 to …
WEB2 days ago · Sept. 19, 2024 5:30 a.m. PT. 3 min read. Following a data a breach that exposed genetic and ancestry information for 6.9 million customers, 23andMe said it will settle a $30 million class action ...
Independent Directors of 23andMe Resign from Board - Yahoo …
WEB2 days ago · SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief ...
23andMe sees independent board directors quit en masse
WEB2 days ago · 23andMe, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 billion.Then its fortunes began to sink. Fading interest in DNA ...
23andMe’s independent directors quit in clash with CEO
WEB2 days ago · SPX. -0.29%. DNA-testing company 23andMe Holding Co’s independent directors resigned en masse late Tuesday as part of a dispute with the company’s leader over her plan to take it private. In a ...
23andMe Board Resigns in New Blow to DNA-Testing Company
WEB2 days ago · Photo: David Paul Morris/Bloomberg News. All seven independent directors of DNA-testing company 23andMe ME -0.29% resigned Tuesday, following a protracted negotiation with founder and Chief ...
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits
WEB2 days ago · September 17, 2024 at 9:22 PM EDT. Save. 23andMe Holding Co.co-founder and Chief Executive Officer Anne Wojcickitold employees that she remains committed to taking the genetic testing company ...
23andMe Therapeutics Announces Phase 2 Results for Two …
WEB5 days ago · SUNNYVALE, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, announced positive preliminary Phase 2 safety and efficacy data from its Phase 1/2a clinical trial covering two new patient cohorts from 23ME-00610 (’610), a first-in …
Addressing Data Security Concerns - Action Plan - 23andMe Blog
WEBDec 5, 2023 · 23andMe has completed its investigation, assisted by third-party forensics experts. We are in the process of notifying affected customers, as required by law. We have taken steps to further protect customer data, including requiring all existing customers to reset their password and requiring two-step verification for all new and existing ...
Turmoil strikes 23andMe as board members resign in dispute with …
WEB1 day ago · Story by Daniel Gilbert. • 17h. The pioneering DNA testing firm 23andMe is in turmoil. Seven independent members of the company’s eight-person board resigned Tuesday, concluding that despite ...
Skip to content